CoChat

Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival

Open access

The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.

Abstract

In chemotherapy-treated breast cancer, wild-type p53 preferentially induces senescence over apoptosis, resulting in a persisting cell population constituting residual disease that drives relapse and poor patient survival via the senescence-associated secretory phenotype. Understanding the properties of tumor cells that allow survival after chemotherapy treatment is paramount. Using time-lapse and confocal microscopy to observe interactions of cells in treated tumors, we show here that chemotherapy-induced senescent cells frequently engulf both neighboring senescent or nonsenescent tumor cells at a remarkable frequency. Engulfed cells are processed through the lysosome and broken down, and cells that have engulfed others obtain a survival advantage. Gene expression analysis showed a marked up-regulation of conserved macrophage-like program of engulfment in chemotherapy-induced senescent cell lines and tumors. Our data suggest compelling explanations for how senescent cells persist in dormancy, how they manage the metabolically expensive process of cytokine production that drives relapse in those tumors that respond the worst, and a function for their expanded lysosomal compartment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1083/jcb.201904051

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Cell-in-cell structures are observed in doxorubicin-treated mouse mammary tumors and breast cancer cell lines. (A) Cells from an MMTV-Wnt1 mammary tumor were plated and infected ex vivo in separate dishes with lentiviruses expressing either H2B-GFP or farnesylated-mCherry. Cells were orthotopically transplanted into the #4 mammary fat pad of C57BL/6j mice, and after tumors formed, cells were mixed and transplanted again in more mice. After these mosaic tumors formed with cells expressing two different markers, mice were treated with doxorubicin. Tumors were harvested during senescent response, sectioned, DAPI stained, imaged on a confocal microscope in three channels, and merged. Z-stack projections display 14 images taken 2 µm apart with a total z range of 24.12 µm. (B) Cells from a second MMTV-Wnt1 tumor were separately infected with lentiviruses expressing GFP and H2B-mCherry as in A, and mosaic transplants composed of these cells were treated, harvested, and imaged. Z-stack projections display 21 images taken 2 µm apart with a total z range of 38.82 µm. Scale bars in A and B represent 50 and 25 µm for wide-field and zoomed images, respectively. Representative images of cell-in-cell structures are depicted. (C and D) Populations of breast cancer cell lines expressing GFP or mCherry were mixed and treated with doxorubicin (DOXO) for 24 h as stated in Materials and methods. 8 d after DOXO addition, 4226 (C) and MCF-7 (D) cells were fixed and DAPI stained, imaged on a fluorescent microscope in three channels, and merged. White arrowheads denote mCherry vesicles present within GFP-positive, senescent cells. Scale bar represents 50 µm.
Figure 1. Cell-in-cell structures are observed in doxorubicin-treated mouse mammary tumors and breast cancer cell lines. (A) Cells from an MMTV-Wnt1 mammary tumor were plated and infected ex vivo in separate dishes with lentiviruses expressing either H2B-GFP or farnesylated-mCherry. Cells were orthotopically transplanted into the #4 mammary fat pad of C57BL/6j mice, and after tumors formed, cells were mixed and transplanted again in more mice. After these mosaic tumors formed with cells expressing two different markers, mice were treated with doxorubicin. Tumors were harvested during senescent response, sectioned, DAPI stained, imaged on a confocal microscope in three channels, and merged. Z-stack projections display 14 images taken 2 µm apart with a total z range of 24.12 µm. (B) Cells from a second MMTV-Wnt1 tumor were separately infected with lentiviruses expressing GFP and H2B-mCherry as in A, and mosaic transplants composed of these cells were treated, harvested, and imaged. Z-stack projections display 21 images taken 2 µm apart with a total z range of 38.82 µm. Scale bars in A and B represent 50 and 25 µm for wide-field and zoomed images, respectively. Representative images of cell-in-cell structures are depicted. (C and D) Populations of breast cancer cell lines expressing GFP or mCherry were mixed and treated with doxorubicin (DOXO) for 24 h as stated in Materials and methods. 8 d after DOXO addition, 4226 (C) and MCF-7 (D) cells were fixed and DAPI stained, imaged on a fluorescent microscope in three channels, and merged. White arrowheads denote mCherry vesicles present within GFP-positive, senescent cells. Scale bar represents 50 µm.CC BY-NC-SA · PubMed Central
Figure 2. DNA damage, microtubule stress, and ectopic p53 activation induce senescence and engulfment of entire cells. (A and B) Doxorubicin (DOXO)-treated, GFP-expressing 4226 (A) or MCF-7 (B) cells were co-plated on a glass coverslip with proliferating, mCherry-expressing cells. 7 d later, coverslips were fixed with 4% formaldehyde and stained for DAPI. Confocal images were captured, and z-stack projections are shown adjacent; representative images are shown. Scale bar represents 10 µm (A) and 20 µm (B). Z-stack projections display 76 images taken 0.2 µm apart totaling 15 µm for A, and 14 images taken 1 µm apart with a total z range of 12.62 µm for B. (C) Mixed populations of GFP- and mCherry-expressing 4226 cells were plated simultaneously at a 1:8 ratio. When near confluence, cells were treated with DMSO, 0.75 µM doxorubicin (DOXO), 10 nM paclitaxel (pacl.), or both and washed off after 24 h. Nutlin to a concentration of 15 µM was applied every other day until fixation and imaging. Average of four independent experiments is shown, error bars indicate SEM; one-way ANOVA and Newman–Keuls posttest was used to determine significance; *, significant compared with DMSO treated. (D) MCF-7 cells were treated as in C using 0.25 µM doxorubicin, 5 nM paclitaxel, and 2.5 µM nutlin. Average of five independent experiments is shown; error bars indicate SEM; one-way ANOVA and Newman–Keuls posttest were used to determine significance; *, significant compared with DMSO treated, P < 0.05. (E and F) 4226 and MCF-7 cells were left untreated or treated with 0.75 and 0.25 µM doxorubicin, respectively, for 24 h. Either NT GFP-expressing cells were co-plated with NT mCherry cells (NT, gray bar) or doxorubicin-treated GFP-expressing cells were co-plated with NT, proliferating mCherry cells (DOXO, purple bars). 7 d after co-plating, cells were fixed and DAPI stained, and random fields were imaged by microscopy. Data shown are the percentage of GFP-expressing cells examined that had one or more DAPI-positive, red vesicles inside them. Average of three independent experiments shown; error bars indicate SEM; significance determined using unpaired t test; **, P < 0.001 (E); **, P < 0.005 (F). (G) 4226 cells were treated and plated as in F. 48 h before scoring, cultures were treated with DMSO or 20 µM QV-D-Oph, a pan-caspase inhibitor. Average of three experiments are shown; not significant by unpaired t test, P = 0.46. (H) Confocal z-stack image of MCF-7 as in B. Representative image of a cell with multiple engulfed cells is shown. Z-stack projections display 12 images taken 2 µm apart with a total z range of 21.5 µm. Scale bar represents 20 µm. (I) Representative image of a senescent 4226 cell plated with NT 4226 cells as in F showing multiple engulfed cells. Scale bar represents 10 µm. (J) Senescent MCF-7 cells were treated with doxorubicin and paclitaxel, as in D. Representative image of multiple sequential engulfments shown. Scale bar represents 50 µm. (K) GFP-expressing MCF-7 cells were treated with 0.75 µM doxorubicin or not on day 0 for 24 h, and then plated on day 1 with NT mCherry-expressing cells. On day 3, the 24-well plate was placed on an IncuCyte and imaged every 2 h until day 11. In cultures of NT mCherry cells mixed with either treated GFP cells (purple line) or NT GFP cells (black line), four different random fields of view were quantified once each day for mCherry cells within GFP cells. Error bar represents SEM; significance was determined by unpaired t test on each day; *, P < 0.05; nonsignificant P values are shown in the figure. (L) Mixed cultures of GFP- and mCherry-expressing MCF-7, MPE600, and 4226 cells were plated and doxorubicin-treated as in C and imaged for fluorescence 7 d later on a Cytation, followed by fixation, SA-βGAL staining, and repeat imaging in color bright field. Shown are examples of matching sequential images of the same cell in fluorescence and color bright field. Arrowheads indicate engulfed cells visible in both images. Scale bars represent 100 µm.
Figure 2. DNA damage, microtubule stress, and ectopic p53 activation induce senescence and engulfment of entire cells. (A and B) Doxorubicin (DOXO)-treated, GFP-expressing 4226 (A) or MCF-7 (B) cells were co-plated on a glass coverslip with proliferating, mCherry-expressing cells. 7 d later, coverslips were fixed with 4% formaldehyde and stained for DAPI. Confocal images were captured, and z-stack projections are shown adjacent; representative images are shown. Scale bar represents 10 µm (A) and 20 µm (B). Z-stack projections display 76 images taken 0.2 µm apart totaling 15 µm for A, and 14 images taken 1 µm apart with a total z range of 12.62 µm for B. (C) Mixed populations of GFP- and mCherry-expressing 4226 cells were plated simultaneously at a 1:8 ratio. When near confluence, cells were treated with DMSO, 0.75 µM doxorubicin (DOXO), 10 nM paclitaxel (pacl.), or both and washed off after 24 h. Nutlin to a concentration of 15 µM was applied every other day until fixation and imaging. Average of four independent experiments is shown, error bars indicate SEM; one-way ANOVA and Newman–Keuls posttest was used to determine significance; *, significant compared with DMSO treated. (D) MCF-7 cells were treated as in C using 0.25 µM doxorubicin, 5 nM paclitaxel, and 2.5 µM nutlin. Average of five independent experiments is shown; error bars indicate SEM; one-way ANOVA and Newman–Keuls posttest were used to determine significance; *, significant compared with DMSO treated, P < 0.05. (E and F) 4226 and MCF-7 cells were left untreated or treated with 0.75 and 0.25 µM doxorubicin, respectively, for 24 h. Either NT GFP-expressing cells were co-plated with NT mCherry cells (NT, gray bar) or doxorubicin-treated GFP-expressing cells were co-plated with NT, proliferating mCherry cells (DOXO, purple bars). 7 d after co-plating, cells were fixed and DAPI stained, and random fields were imaged by microscopy. Data shown are the percentage of GFP-expressing cells examined that had one or more DAPI-positive, red vesicles inside them. Average of three independent experiments shown; error bars indicate SEM; significance determined using unpaired t test; **, P < 0.001 (E); **, P < 0.005 (F). (G) 4226 cells were treated and plated as in F. 48 h before scoring, cultures were treated with DMSO or 20 µM QV-D-Oph, a pan-caspase inhibitor. Average of three experiments are shown; not significant by unpaired t test, P = 0.46. (H) Confocal z-stack image of MCF-7 as in B. Representative image of a cell with multiple engulfed cells is shown. Z-stack projections display 12 images taken 2 µm apart with a total z range of 21.5 µm. Scale bar represents 20 µm. (I) Representative image of a senescent 4226 cell plated with NT 4226 cells as in F showing multiple engulfed cells. Scale bar represents 10 µm. (J) Senescent MCF-7 cells were treated with doxorubicin and paclitaxel, as in D. Representative image of multiple sequential engulfments shown. Scale bar represents 50 µm. (K) GFP-expressing MCF-7 cells were treated with 0.75 µM doxorubicin or not on day 0 for 24 h, and then plated on day 1 with NT mCherry-expressing cells. On day 3, the 24-well plate was placed on an IncuCyte and imaged every 2 h until day 11. In cultures of NT mCherry cells mixed with either treated GFP cells (purple line) or NT GFP cells (black line), four different random fields of view were quantified once each day for mCherry cells within GFP cells. Error bar represents SEM; significance was determined by unpaired t test on each day; *, P < 0.05; nonsignificant P values are shown in the figure. (L) Mixed cultures of GFP- and mCherry-expressing MCF-7, MPE600, and 4226 cells were plated and doxorubicin-treated as in C and imaged for fluorescence 7 d later on a Cytation, followed by fixation, SA-βGAL staining, and repeat imaging in color bright field. Shown are examples of matching sequential images of the same cell in fluorescence and color bright field. Arrowheads indicate engulfed cells visible in both images. Scale bars represent 100 µm.CC BY-NC-SA · PubMed Central
Figure 3. Non–breast cancer cells and TP53 mutant cells that survive doxorubicin treatment engulf neighbors. (A–E) The indicated GFP- or mCherry-expressing cells were co-plated with cells of the opposite color as in Fig. 2 E that were either NT or doxorubicin treated (DOXO). After 7 d, images of engulfed cells were captured (left) and random fields from triplicate wells were quantitated for engulfment (graphs, right). More than 100 treated cells were scored for engulfment in each well and percentages determined. Error bars represent SEM. (F) mCherry-expressing MCF-7 cells with both alleles of TP53 edited by CRISPR-Cas9 were doxorubicin treated as in A and co-plated with GFP-expressing MCF-7 cells. After 7 d, images were captured of representative remaining TP53 edited cells that had engulfed.
Figure 3. Non–breast cancer cells and TP53 mutant cells that survive doxorubicin treatment engulf neighbors. (A–E) The indicated GFP- or mCherry-expressing cells were co-plated with cells of the opposite color as in Fig. 2 E that were either NT or doxorubicin treated (DOXO). After 7 d, images of engulfed cells were captured (left) and random fields from triplicate wells were quantitated for engulfment (graphs, right). More than 100 treated cells were scored for engulfment in each well and percentages determined. Error bars represent SEM. (F) mCherry-expressing MCF-7 cells with both alleles of TP53 edited by CRISPR-Cas9 were doxorubicin treated as in A and co-plated with GFP-expressing MCF-7 cells. After 7 d, images were captured of representative remaining TP53 edited cells that had engulfed.CC BY-NC-SA · PubMed Central
Figure 4. Engulfed cells are processed to the lysosome. (A) GFP-expressing 4226 cells were treated with 0.75 µM doxorubicin (DOXO) for 24 h and then co-plated with clear (uninfected), NT 4226 cells. After 7 d, LysoTracker and Hoechst dye was added to cocultures, followed by imaging. Arrowheads indicate clear cells within GFP-expressing senescent cells in various states of Hoechst and LysoTracker positivity. Scale bar represents 20 µm. (B) LysoTracker staining was quantitated in three separate 4226 engulfment experiments. A total of 103 senescent cells were found to have engulfed another cell and were counted. LysoTracker-positive vesicles that were both DAPI positive and completely surrounded by GFP cytoplasm from the engulfing cell were counted as positive, while vesicles that were also completely surrounded by GFP and were DAPI positive but were not LysoTracker positive were counted as negative. Significance determined by unpaired t test; **, P < 0.001. (C and D) MCF-7 cells expressing LAMP1-GFP were treated with doxorubicin and then co-plated with NT mCherry cells. 7 d later, cells were fixed and confocal microscope images were captured in three channels and merged. Z-stack projections are shown adjacent and below. Representative images shown. Scale bar represents 20 µm. Z-stack projections display 15 images taken 2 µm apart with a total z range of 28.02 µm for C, 22 images taken 1 µm apart for a total of 20.48 µm (D, left), and 33 images taken 1 µm apart totaling 31.72 µm (D, right). (E and F) Cells expressing GFP were doxorubicin treated or not for 24 h and then co-plated as in Fig. 2 (E and F). 5 d after plating, vehicle or chloroquine was added to final concentration of 20 or 10 µM for MCF-7 and 4226, respectively, and 2 d later MCF-7 (E) and 4226 (F) were fixed and DAPI stained. Engulfment percentage was determined for NT cells mixed with NT cells (gray bar), doxorubicin-treated cells mixed with NT cells (DOXO, purple bars), and doxorubicin-treated cells mixed with NT cells followed by chloroquine treatment (DOXO+CQ, green bars). Three (E) and five (F) individual experiments were performed; *, P < 0.05 determined by unpaired t test between doxorubicin treated with or without chloroquine. Errors bars represent SEM.
Figure 4. Engulfed cells are processed to the lysosome. (A) GFP-expressing 4226 cells were treated with 0.75 µM doxorubicin (DOXO) for 24 h and then co-plated with clear (uninfected), NT 4226 cells. After 7 d, LysoTracker and Hoechst dye was added to cocultures, followed by imaging. Arrowheads indicate clear cells within GFP-expressing senescent cells in various states of Hoechst and LysoTracker positivity. Scale bar represents 20 µm. (B) LysoTracker staining was quantitated in three separate 4226 engulfment experiments. A total of 103 senescent cells were found to have engulfed another cell and were counted. LysoTracker-positive vesicles that were both DAPI positive and completely surrounded by GFP cytoplasm from the engulfing cell were counted as positive, while vesicles that were also completely surrounded by GFP and were DAPI positive but were not LysoTracker positive were counted as negative. Significance determined by unpaired t test; **, P < 0.001. (C and D) MCF-7 cells expressing LAMP1-GFP were treated with doxorubicin and then co-plated with NT mCherry cells. 7 d later, cells were fixed and confocal microscope images were captured in three channels and merged. Z-stack projections are shown adjacent and below. Representative images shown. Scale bar represents 20 µm. Z-stack projections display 15 images taken 2 µm apart with a total z range of 28.02 µm for C, 22 images taken 1 µm apart for a total of 20.48 µm (D, left), and 33 images taken 1 µm apart totaling 31.72 µm (D, right). (E and F) Cells expressing GFP were doxorubicin treated or not for 24 h and then co-plated as in Fig. 2 (E and F). 5 d after plating, vehicle or chloroquine was added to final concentration of 20 or 10 µM for MCF-7 and 4226, respectively, and 2 d later MCF-7 (E) and 4226 (F) were fixed and DAPI stained. Engulfment percentage was determined for NT cells mixed with NT cells (gray bar), doxorubicin-treated cells mixed with NT cells (DOXO, purple bars), and doxorubicin-treated cells mixed with NT cells followed by chloroquine treatment (DOXO+CQ, green bars). Three (E) and five (F) individual experiments were performed; *, P < 0.05 determined by unpaired t test between doxorubicin treated with or without chloroquine. Errors bars represent SEM.CC BY-NC-SA · PubMed Central
Figure 5. Engulfment by doxorubicin (DOXO)-induced senescent cells is distinct from e-cadherin–dependent entosis. (A and B) MCF-7, 4226, and MPE600 cells, proliferating and 8 d after doxorubicin treatment, were placed in suspension in low-adhesion plates in the presence or absence of 10 µM ROCK inhibitor Y-27632 (ROCKi) for 6 h, followed by cytospin, fixation, and imaging, along with cells cytospun immediately after suspension (0 h). (A) Number of entosis cells and total number of cells from high-power phase fields were quantified and percentages were graphed. Individual data points are shown; error bars represent SEM. Data represent at least two separate experiments. (B) Representative examples of NT cells and cells 8 d after doxorubicin (DOXO) treatment undergoing entosis, denoted by white arrowheads. Scale bar represents 50 µm. (C) Indicated cell lines were doxorubicin treated and plated for engulfment assays in triplicate as in Figs. 2 E and 3 A. In an additional group, 10 µM ROCK inhibitor Y-27632 was added every other day. Cultures were followed up to 8 d after doxorubicin on an IncuCyte, and cell-in-cell structures were quantified and graphed on day 8. Graphs show mean percentages from triplicate wells (all three data points are shown) of GFP-expressing cells (NT or DOXO) with an NT mCherry-expressing cell inside them. Error bars represent SEM. Data shown are representative of at least two independent experiments. (D) Untreated GFP-expressing MCF-7 cells (NT) were plated as in Fig. 2 E with NT or doxorubicin-treated (DOXO) clear MCF-7 parental cells. Cultures were followed for 5 d on IncuCyte, and cells were fixed, stained for e-cadherin (CDH1), and imaged on IncuCyte again. Shown are representative images of senescent clear cells that had previously engulfed another cell (indicated by arrowheads, verified in time lapse to be a live cell engulfment) making contact with NT cells (top two panels; open arrowhead indicates an NT cell intruding into the senescent cell). Lower panel shows e-cadherin staining of contacts made between NT clear and NT GFP-expressing cells. (E) MCF-7 cells with knockout of the gene for e-cadherin (CDH1-KO) and the parental line from which they were derived were stained for E-cadherin. Scale bar represents 50 µm. (F) GFP- and mCherry-expressing MCF-7 parental and CDH1-KO cell lines were plated and doxorubicin treated in triplicate as in Fig. 2 C. Cultures were imaged on IncuCyte, and 6 d after doxorubicin, cell-in-cell structures were quantified and graphed to show mean percentages of GFP-expressing cells (NT-NT or DOXO-DOXO) with an mCherry-expressing cell inside them (all three data points are shown). Error bars represent SEM. Data shown are representative of two independent experiments. (G) Representative images of engulfments occurring in cultures from F. Arrowheads indicate engulfed treated cells within other treated cells from both MCF-7 parental and CDH1-KO cells. Scale bar represents 100 µm. Data shown are representative of at least two independent experiments.
Figure 5. Engulfment by doxorubicin (DOXO)-induced senescent cells is distinct from e-cadherin–dependent entosis. (A and B) MCF-7, 4226, and MPE600 cells, proliferating and 8 d after doxorubicin treatment, were placed in suspension in low-adhesion plates in the presence or absence of 10 µM ROCK inhibitor Y-27632 (ROCKi) for 6 h, followed by cytospin, fixation, and imaging, along with cells cytospun immediately after suspension (0 h). (A) Number of entosis cells and total number of cells from high-power phase fields were quantified and percentages were graphed. Individual data points are shown; error bars represent SEM. Data represent at least two separate experiments. (B) Representative examples of NT cells and cells 8 d after doxorubicin (DOXO) treatment undergoing entosis, denoted by white arrowheads. Scale bar represents 50 µm. (C) Indicated cell lines were doxorubicin treated and plated for engulfment assays in triplicate as in Figs. 2 E and 3 A. In an additional group, 10 µM ROCK inhibitor Y-27632 was added every other day. Cultures were followed up to 8 d after doxorubicin on an IncuCyte, and cell-in-cell structures were quantified and graphed on day 8. Graphs show mean percentages from triplicate wells (all three data points are shown) of GFP-expressing cells (NT or DOXO) with an NT mCherry-expressing cell inside them. Error bars represent SEM. Data shown are representative of at least two independent experiments. (D) Untreated GFP-expressing MCF-7 cells (NT) were plated as in Fig. 2 E with NT or doxorubicin-treated (DOXO) clear MCF-7 parental cells. Cultures were followed for 5 d on IncuCyte, and cells were fixed, stained for e-cadherin (CDH1), and imaged on IncuCyte again. Shown are representative images of senescent clear cells that had previously engulfed another cell (indicated by arrowheads, verified in time lapse to be a live cell engulfment) making contact with NT cells (top two panels; open arrowhead indicates an NT cell intruding into the senescent cell). Lower panel shows e-cadherin staining of contacts made between NT clear and NT GFP-expressing cells. (E) MCF-7 cells with knockout of the gene for e-cadherin (CDH1-KO) and the parental line from which they were derived were stained for E-cadherin. Scale bar represents 50 µm. (F) GFP- and mCherry-expressing MCF-7 parental and CDH1-KO cell lines were plated and doxorubicin treated in triplicate as in Fig. 2 C. Cultures were imaged on IncuCyte, and 6 d after doxorubicin, cell-in-cell structures were quantified and graphed to show mean percentages of GFP-expressing cells (NT-NT or DOXO-DOXO) with an mCherry-expressing cell inside them (all three data points are shown). Error bars represent SEM. Data shown are representative of two independent experiments. (G) Representative images of engulfments occurring in cultures from F. Arrowheads indicate engulfed treated cells within other treated cells from both MCF-7 parental and CDH1-KO cells. Scale bar represents 100 µm. Data shown are representative of at least two independent experiments.CC BY-NC-SA · PubMed Central
Figure 6. Doxorubicin (DOXO)-induced senescent cells are proficient in phagocytosis. (A–C) pHrodo-labeled Jurkat cells that were NT (nonapoptotic) or treated with doxorubicin for 24 h (apoptotic) were placed onto cultures of RAW264 macrophages and proliferating and senescent 4226 cells. After 2 d, Jurkats were washed off and plates were imaged and quantitated on IncuCyte for the red fluorescence emitted after the phagocytosis of Jurkat cells and their transport to lysosome. (A) Representative images of doxorubicin-treated, senescent 4226 cells (DOXO), NT 4226 cells, and RAW264 macrophage cell line. Scale bar represents 200 µm. (B) Representative phase and red fluorescence images were captured over a time course of a senescent 4226 cell engulfing pHrodo-labeled cells and processing them to the lysosome. Scale bar represents 100 µm; time of capture after addition of pHrodo Jurkats is shown. Open arrowheads indicate pHrodo Jurkats before engulfment, and closed arrowheads indicate pHrodo fluorescence activation at low pH, such as occurs in the lysosome. (C) Total red fluorescence in each well was quantified and normalized to the cell number in each well. The mean and individual data points from triplicate wells were plotted; error bar represents SEM. (D) Proliferating and senescent 4226 cells were serum starved for 1 h, 60 µg/ml of 70-kD Texas Red Dextran was added, 30 min later cells were washed and fixed with 4% formaldehyde, and images were captured. Representative images shown. Scale bar represents 20 µm. Data shown are representative of at least two independent experiments.
Figure 6. Doxorubicin (DOXO)-induced senescent cells are proficient in phagocytosis. (A–C) pHrodo-labeled Jurkat cells that were NT (nonapoptotic) or treated with doxorubicin for 24 h (apoptotic) were placed onto cultures of RAW264 macrophages and proliferating and senescent 4226 cells. After 2 d, Jurkats were washed off and plates were imaged and quantitated on IncuCyte for the red fluorescence emitted after the phagocytosis of Jurkat cells and their transport to lysosome. (A) Representative images of doxorubicin-treated, senescent 4226 cells (DOXO), NT 4226 cells, and RAW264 macrophage cell line. Scale bar represents 200 µm. (B) Representative phase and red fluorescence images were captured over a time course of a senescent 4226 cell engulfing pHrodo-labeled cells and processing them to the lysosome. Scale bar represents 100 µm; time of capture after addition of pHrodo Jurkats is shown. Open arrowheads indicate pHrodo Jurkats before engulfment, and closed arrowheads indicate pHrodo fluorescence activation at low pH, such as occurs in the lysosome. (C) Total red fluorescence in each well was quantified and normalized to the cell number in each well. The mean and individual data points from triplicate wells were plotted; error bar represents SEM. (D) Proliferating and senescent 4226 cells were serum starved for 1 h, 60 µg/ml of 70-kD Texas Red Dextran was added, 30 min later cells were washed and fixed with 4% formaldehyde, and images were captured. Representative images shown. Scale bar represents 20 µm. Data shown are representative of at least two independent experiments.CC BY-NC-SA · PubMed Central
Figure 7. Gene expression analysis of doxorubicin-treated tumors and cell lines reveals enrichment of phagocytosis signatures. (A–E) GSEA was performed with RNA-seq data from MMTV-Wnt1 mammary tumors (p53 wild type, red line; p53-null, black line) for NT (Ctl) versus doxorubicin-treated cells harvested 24 h after the final treatment (left panels); from control MCF-7 cells and MCF-7 cells 8 d after doxorubicin (0.5 µM) treatment (middle panels); and from NT 4226 cells versus cells 24 h (green line) and 8 d (blue line) after doxorubicin (0.75 µM) or treated for 24 h (red line) and 8 d (yellow line) with nutlin (15 µM every other day), as indicated. RNA-seq was performed on MCF-7 and 4226 using samples from three independent experiments each. RNA was extracted from six doxorubicin-treated and six NT MMTV-Wnt1 tumor samples and sent for sequencing. GSEA was performed for “HALLMARK_E2F_TARGETS” (A); KEGG_LYSOSOME (B); GO_PHAGOCYTOSIS_ENGULFMENT (C); GO_PHAGOCYTOSIS (D); and genes involved in macrophage sensing their environment as listed in Ley et al. (2016) (E). Enrichment scores (ES) were plotted. Statistical analysis using GSEA software is provided as false discovery rate q values (significance at false discovery rate q < 0.25) in Table S2. GO, gene ontology.
Figure 7. Gene expression analysis of doxorubicin-treated tumors and cell lines reveals enrichment of phagocytosis signatures. (A–E) GSEA was performed with RNA-seq data from MMTV-Wnt1 mammary tumors (p53 wild type, red line; p53-null, black line) for NT (Ctl) versus doxorubicin-treated cells harvested 24 h after the final treatment (left panels); from control MCF-7 cells and MCF-7 cells 8 d after doxorubicin (0.5 µM) treatment (middle panels); and from NT 4226 cells versus cells 24 h (green line) and 8 d (blue line) after doxorubicin (0.75 µM) or treated for 24 h (red line) and 8 d (yellow line) with nutlin (15 µM every other day), as indicated. RNA-seq was performed on MCF-7 and 4226 using samples from three independent experiments each. RNA was extracted from six doxorubicin-treated and six NT MMTV-Wnt1 tumor samples and sent for sequencing. GSEA was performed for “HALLMARK_E2F_TARGETS” (A); KEGG_LYSOSOME (B); GO_PHAGOCYTOSIS_ENGULFMENT (C); GO_PHAGOCYTOSIS (D); and genes involved in macrophage sensing their environment as listed in Ley et al. (2016) (E). Enrichment scores (ES) were plotted. Statistical analysis using GSEA software is provided as false discovery rate q values (significance at false discovery rate q < 0.25) in Table S2. GO, gene ontology.CC BY-NC-SA · PubMed Central
Figure 8. Senescent cells that have engulfed a cell have a survival advantage. (A–D) H2B-GFP–expressing senescent 4226 (A and B) or MCF-7 (C and D) cells were co-plated with NT H2B-mCherry–expressing 4226 and MCF-7 cells, respectively. 7 d after coplating, cells were trypsinized and sorted one cell per well of a 96-well plate. Each cell was confirmed microscopically and marked as double positive (engulfed, black line) or GFP positive only (not engulfed, red line) and followed over time. (A) Four individual experiments were sorted; a total of n = 23 double-positive and n = 30 GFP-only 4226 cells were followed. Significance was determined by log-rank Mantel–Cox test, *, P < 0.05. (C) One experiment was sorted; a total of n = 47 double-positive and n = 50 GFP-only cells were followed. Experiment terminated at 12 d. Significance was determined by log-rank Mantel–Cox test, *, P < 0.05. Examples of GFP+-only cells that died are shown in upper panels of B and D; examples of surviving GFP-expressing cells with an mCherry vesicle within them (red arrowhead) are shown in lower panels of B and D. Scale bars represent 50 µm.
Figure 8. Senescent cells that have engulfed a cell have a survival advantage. (A–D) H2B-GFP–expressing senescent 4226 (A and B) or MCF-7 (C and D) cells were co-plated with NT H2B-mCherry–expressing 4226 and MCF-7 cells, respectively. 7 d after coplating, cells were trypsinized and sorted one cell per well of a 96-well plate. Each cell was confirmed microscopically and marked as double positive (engulfed, black line) or GFP positive only (not engulfed, red line) and followed over time. (A) Four individual experiments were sorted; a total of n = 23 double-positive and n = 30 GFP-only 4226 cells were followed. Significance was determined by log-rank Mantel–Cox test, *, P < 0.05. (C) One experiment was sorted; a total of n = 47 double-positive and n = 50 GFP-only cells were followed. Experiment terminated at 12 d. Significance was determined by log-rank Mantel–Cox test, *, P < 0.05. Examples of GFP+-only cells that died are shown in upper panels of B and D; examples of surviving GFP-expressing cells with an mCherry vesicle within them (red arrowhead) are shown in lower panels of B and D. Scale bars represent 50 µm.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Research works printed but not linked: 1

  1. Tonnessen-Murray C., Lozano G., and Jackson J.G. 2016 The p53 Protein: From Cell Regulation to Cancer. In Lozano G., and Levine A.J., editors. The p53 Protein: From Cell Regulation to Cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 173– 186.

Cited by

See all 127

Metadata

Authors
Tonnessen-Murray, C. A., Frey, W. D., Rao, S. G., Shahbandi, A., Ungerleider, N. A., Olayiwola, J. O., Murray, L. B., Vinson, B. T., Chrisey, D. B., Lord, C. J., & Jackson, J. G.
Affiliations
  • Tulane University (US)
  • Institute of Cancer Research (GB)
Corresponding author
Jackson, James G.
Venue
Journal of Cell Biology
Published
2019-09-17
Volume
218
Issue
11
Pages
3827-3844
ISSN
  • 0021-9525 (ISSN-L)
  • 1540-8140
OpenAlex
W2973542731
Cited by
127
References
59
Citations by year
2026: 7 · 2025: 11 · 2024: 23 · 2023: 16 · 2022: 20 · 2021: 18 · 2020: 25 · 2019: 6
FWCI
11.83
Type
journal article
Language
en
Open access
Locations
  • The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Defense (W81XWH-14-1-0216)
  • National Institutes of Health
  • National Institute of General Medical Sciences (1P30GM114732-01, U54 GM104940)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
chemotherapy-induced senescence, senescence-associated secretory phenotype, breast cancer, p53, cell engulfment, lysosomal degradation, tumor cell survival, relapse, cytokine production, lysosomes
MeSH terms
Animals, Antibiotics, Antineoplastic, Cell Survival, Doxorubicin, Humans, Tumor Cells, Cultured, Cellular Senescence, Cell Proliferation, Mice, MCF-7 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.